Background. Recent trials report the short-term efficacy of tenofovir-based pre-exposure
prophylaxis (PrEP) for prevention of human immunodeficiency virus (HIV) infection. PrEP's …

Abstract Background. For young South African women at risk for human immunodeficiency
virus (HIV) infection, preexposure prophylaxis (PrEP) is one of the few effective prevention …

Background. Long-acting injectable antiretrovirals such as rilpivirine (RPV) could promote
adherence to preexposure prophylaxis (PrEP) for human immunodeficiency virus (HIV) …

Background. The combination of tenofovir and emtricitabine shows promise as HIV
preexposure prophylaxis (PrEP). We sought to forecast clinical, epidemiologic, and …

As oral tenofovir-based regimens for preexposure prophylaxis (PrEP) are adopted as
standard of care for HIV prevention, their utilization in clinical trials among women in …

Background: Daily oral antiretroviral preexposure prophylaxis (PrEP) is a promising strategy
for prevention of HIV-1 acquisition. Three clinical trials demonstrated PrEP efficacy; …

BACKGROUND: Recent trials report the efficacy of continuous tenofovir‐based pre‐
exposure prophylaxis (PrEP) for prevention of HIV infection. The cost effectiveness of 'on …

The World Health Organization has issued an early release revision to its antiretroviral
guidelines in which PrEP (pre-exposure prophylaxis in the form of daily oral, fixed dose …

Background Mathematical modelers have given little attention to the question of how pre-
exposure prophylaxis (PrEP) may impact on a generalized national HIV epidemic and its …

Pre-exposure prophylaxis (PrEP) is a promising intervention to prevent HIV acquisition, with
benefits both to the individual and to population-level health. PrEP is an opportunity to …